For example, there are some people who are advised not to take the medication, including those who have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
When an intervention is studied with a clear protocol, a defined participant group, and monitored outcomes, clinicians and consumers can make informed choices
In most cases, this delay is minor, but it is a factor your doctor should be aware of
Rapid Advancements in GLP-1 and Multi-Agonist Therapies: The obesity treatment landscape has transformed with the success of GLP-1 receptor agonists and next-generation incretin-based therapies
In October 2024, the FDA removed Eli Lillys tirzepatride from its shortages list, ending permission for compounding pharmacies to produce copycat versions